AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00175-08v1
52/8/2977    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Schneider, I.
Right arrow Articles by Bauernfeind, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, I.
Right arrow Articles by Bauernfeind, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2008, p. 2977-2979, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.00175-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

VIM-15 and VIM-16, Two New VIM-2-Like Metallo-β-Lactamases in Pseudomonas aeruginosa Isolates from Bulgaria and Germany{triangledown}

Ines Schneider,1 Emma Keuleyan,2 Rudolf Rasshofer,3 Rumyana Markovska,4 Anne Marie Queenan,5 and Adolf Bauernfeind1*

MICOER-Institute, Munich, Germany,1 Medical Institute, Ministry of the Interior, Sofia, Bulgaria,2 Medizinisches Versorgungszentrum Labor Dr. Tiller and Partner, Munich, Germany,3 Department of Microbiology, Medical University, Sofia, Bulgaria,4 Johnson & Johnson Pharmaceutical Research and Development, Raritan, New Jersey5

Received 7 February 2008/ Returned for modification 27 March 2008/ Accepted 28 May 2008

Two Pseudomonas aeruginosa urine isolates from Bulgaria and Germany produced two new VIM-2 variants. VIM-15 had one amino acid substitution (Tyr218Phe) which caused a significant increase in hydrolytic efficiency. The substitution Ser54Leu, characterizing VIM-16, showed no influence on enzyme activity. Both genes were part of class I integrons located in the chromosome.


* Corresponding author. Mailing address: MICOER-Institute, Hesseloherstrasse 4, 80802 Munich, Germany. Phone and fax: 49-89-3889 8766. E-mail: bauernfeind{at}aol.com

{triangledown} Published ahead of print on 2 June 2008.


Antimicrobial Agents and Chemotherapy, August 2008, p. 2977-2979, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.00175-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.